Skip to the page

Data / Form D filings / Cocrystal Pharma, Inc.

Cocrystal Pharma, Inc.: Form D filings

Cocrystal Pharma, Inc., a pharmaceuticals company in Tucker, GA, filed 17 Form D notices with the SEC between 2012 and 2017. The latest, on May 2, 2017, reports $3 million sold of a $3 million offering to 3 investors.

Find out what Cocrystal Pharma, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
1860 MONTREAL ROAD, Tucker, GA, 30084
Phone
(678) 892-8800
Industry
Pharmaceuticals
Entity type
Corporation
Incorporated in
Delaware
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1412486

The full lists. Form D filings in Georgia: 1,337 rows, $66.85, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
May 2, 2017New notice$3,000,000$3,000,000$03Apr 25, 2017sec.gov
Sep 15, 2016New notice$4,008,201$4,008,201$04Sep 1, 2016sec.gov
Mar 30, 2016New notice$5,004,370$5,004,370$012Mar 15, 2016sec.gov
Jan 31, 2014New notice$2,750,000$2,750,000$08Jan 16, 2014sec.gov
Jan 17, 2014New notice$0$0$023Jan 2, 2014sec.gov
Nov 5, 2013New notice$3,500,000$3,500,000$022Oct 22, 2013sec.gov
Sep 5, 2013New notice$2,000,000$2,000,000$01Aug 26, 2013sec.gov
Apr 22, 2013New noticeIndefinite$800,000Indefinite5Apr 12, 2013sec.gov
Jun 25, 2012New notice$200,000$200,000$02Jun 13, 2012sec.gov
May 29, 2012New notice$250,000$250,000$01Apr 18, 2012sec.gov
Apr 26, 2012New notice$2,250,000$2,250,000$010Mar 29, 2011sec.gov
Apr 25, 2012New notice$250,000$250,000$01Nov 30, 2011sec.gov
Apr 25, 2012New notice$455,000$455,000$05Oct 31, 2011sec.gov
Apr 25, 2012New notice$500,000$500,000$01Sep 22, 2011sec.gov
Mar 20, 2012New notice$1,000,000$1,000,000$01Mar 13, 2012sec.gov
Mar 9, 2012New notice$2,300,000$2,300,000$03Feb 24, 2012sec.gov
Jan 26, 2012New notice$650,000$650,000$03Jan 11, 2012sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Steven D. RubinDirector
David S. BlockDirector
Raymond F. SchinaziDirector
Phillip S. FrostDirector
Sam F. LeeExecutive Officer
Jane H. HsiaoDirector
James F. MartinExecutive Officer
Gary WilcoxExecutive Officer, Director

Other pharmaceuticals companies in Georgia that filed recently

Every Form D from the week of May 1, 2017 · All recent filings in Georgia · All recent Pharmaceuticals filings

Read from SEC EDGAR. Amount sold is what Cocrystal Pharma, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.

$10 of credit on sign-up, no card.